Evidence map›Paper›PMID 29554894›Full record

ArticleBMC public health2018

Perceived access and barriers to care among illicit drug users and hazardous drinkers: findings from the Seek, Test, Treat, and Retain data harmonization initiative (STTR).

Mika Matsuzaki, Quan M Vu, Marya Gwadz, Joseph A C Delaney, Irene Kuo, Maria Esther Perez Trejo, William E Cunningham, Chinazo O Cunningham, Katerina Christopoulos

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Mika MatsuzakiCollaborative Health Studies Coordinating Center, University of Washington, Building 29, 6200 NE 74th St, Seattle, WA, 98115, USA. m0@uw.edu.ORCID 0000-0002-7020-3757
Quan M VuJohns Hopkins University, 615 N Wolfe St, Baltimore, MD, 21205, USA.
Marya GwadzCenter for Drug Use and HIV Research, Rory Meyers College of Nursing, New York University, New York, NY, 10003, USA.
Joseph A C DelaneyCollaborative Health Studies Coordinating Center, University of Washington, Building 29, 6200 NE 74th St, Seattle, WA, 98115, USA.
Irene KuoGeorge Washington University, Milken Institute School of Public Health, Department of Epidemiology and Biostatistics, 950 New Hampshire Avenue NW, Suite 500, Washington, DC, 20052, USA.
Maria Esther Perez TrejoCollaborative Health Studies Coordinating Center, University of Washington, Building 29, 6200 NE 74th St, Seattle, WA, 98115, USA.
William E CunninghamDepartment of Medicine, Div GIM & HSR, Geffen School of Medicine, UCLA and Department of Health Policy and Management, Fielding School of Public Health, UCLA, Los Angeles, CA, USA.
Chinazo O CunninghamAlbert Einstein College of Medicine & Montefiore Medical Center, 111 East 210th Street, Bronx, NY, 10467, USA.
Katerina ChristopoulosDivision of HIV, ID and Global Medicine, Zuckerberg San Francisco General, University of California San Francisco, 995 Potrero Ave, 4th Floor, San Francisco, CA, 94110, USA.
University of Washington · USAlbert Einstein College of Medicine · USJohns Hopkins University · USMilken Institute · USNew York University · USUCLA Health · USUniversity of California, San Francisco · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
The Center for Health Improvement of Minority ElderlyP30AG021684 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Homero Erwin del Pino · 2002 to 2026
$19.7M
NRSA Training CoreTL1TR001883 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALEX BUI, Nina Thawata Harawa · 2016 to 2026
$8.6M
Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIVR01DA032083 · NIDA · NEW YORK UNIVERSITY · PI GWADZ, MARYA · 2011 to 2015
$7.5M
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)U01AA020793 · NIAAA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., LAU, BRYAN · 2011 to 2020
$5.8M
Seek, Test, Treat: An Integrated Jail-Prison-Community Model for IllinoisR01DA030796 · NIDA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI OUELLET, LAWRENCE J, PUISIS, MICHAEL · 2010 to 2015
$5.5M
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV CareR01DA030781 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CUNNINGHAM, WILLIAM EMERY · 2010 to 2015
$4.5M
Seek, Test, Treat, and Retain Data Harmonization Coordinating CenterU01DA037702 · NIDA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., DELANEY, JOSEPH AUSTIN · 2014 to 2019
$3.8M
Abstinence Reinforcing Contingency Management to Suppress HIV Viral LoadR01DA032110 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CUNNINGHAM, CHINAZO · 2011 to 2015
$3.6M
HIV intervention models for criminal justice involved substance-using Black MSMR01DA039934 · NIDA · UNIVERSITY OF CHICAGO · PI FUJIMOTO, KAYO, HARAWA, NINA THAWATA · 2015 to 2019
$3.6M
NCATS NIH HHS TL1 TR001883NCATS NIH HHS TL1TR001883NCATS NIH HHS UL1 TR001881NHLBI NIH HHS R42 HL086294NIAAA NIH HHS U01 AA020793NIA NIH HHS P30 AG021684NIA NIH HHS P30-AG021684NIDA NIH HHS 1R01DA032083NIDA NIH HHS 1R01DA032100NIDA NIH HHS 5R01DA030771NIDA NIH HHS 5U01DA037702NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA030771NIDA NIH HHS R01 DA030781NIDA NIH HHS R01 DA030796NIDA NIH HHS R01 DA032057NIDA NIH HHS R01 DA032083NIDA NIH HHS R01 DA032100NIDA NIH HHS R01 DA032110NIDA NIH HHS R01 DA039934NIDA NIH HHS U01 DA037702NIMHD NIH HHS R01 MD011773NIMH NIH HHS P30 MH058107NIMH NIH HHS R01 MD011773NIMH NIH HHS R01 MH103076NINR NIH HHS R01 NR017334
6 · The paper itself

Abstract

backgroundIllicit drug use (DU) and hazardous drinking (HD) among marginalized populations may be associated with greater barriers to care.

methodsWe used baseline data on the participants of the Seek, Test, Treat, and Retain data harmonization initiative. DU includes use of any illicit drugs within the past 6 months. HD was defined as scores ≥8 for men and ≥ 7 for women on Alcohol Use Disorders Identification Test within the past 12 months. Social support scores were assigned by summing scores from individual questions related to social support. Two outcomes for multivariable regression models and mediation analysis were perceived access to care and perceived barriers to care scores, calculated from summated points from individual questions within each domain. All models were adjusted for age, gender, race/ethnicity, and social support and stratified by HIV status.

resultsAmong 1403 illicit drug users and 4984 non-drug users, the mean age was 39.6 ± 12.2 years old, 71% were male, 57% African Americans, and 39% Hispanic/Latinos. Over 25% reported difficulties in covering medical costs and finding transportation to health care facilities and greater proportions of drug users and hazardous drinkers reported these issues than non-DU/non-HD. In multivariable models, DU and HD were both independently associated with having greater barriers to care (β: 0.49 (95% confidence interval: 0.19 to 0.79) p < 0.01; 0.31 (0.18 to 0.45) < 0.01) in HIV-negative participants. Neither DU nor HD was strongly associated with barriers to care for HIV-positive participants. Social support was associated with better perceived access to care and fewer barriers to care in the HIV-negative participants.

conclusionThe current study found that financial burdens of care, logistical difficulties in accessing care, and low social support were common challenges among individuals using illicit drugs and/or drinking hazardously. Addressing structural barriers and strengthening social support may be important strategies to improve health care among marginalized populations, regardless of HIV status.

Indexed as

Attitude to HealthDangerous BehaviorHealth Services AccessibilityIllicit DrugsAdultAlcohol DrinkingDrug UsersFemaleHumansMaleMiddle AgedSubstance-Related DisordersIllicit DrugsBarriers to careHIV/AIDSRace/ethnicitySocial supportSubstance use

Identifiers

PMID29554894
PMCPMC5859651
OpenAlexW2799580103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.